ArticleThe Lancet regional health. Southeast Asia2025
Beyond immunogenicity in XBB.1.5 subunit COVID-19 boosters focusing on durability, dosing, and target populations: authors reply.
Subhash Thuluva et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.